Synergistic therapies of cannabidiol with hypothermia for neuroprotection
View Patent ↗The present invention relates to a method of treating newborn hypoxic-ischemic encephalopathy (NHIE). Such method comprises administering the phytocannabinoid cannabidiol (CBD) in combination with therapeutic hypothermia to a newborn subject suffering from NHIE. Preferably the CBD is in the form of a plant extract, alternatively the CBD is in a pure or isolated form.
1. A method for treatment of newborn hypoxic-ischemic encephalopathy (NHIE) comprising administering to a newborn human suffering from NHIE a combination of cannabidiol (CBD) with therapeutic hypothermia, wherein the CBD is a non-CB1 agonist.
2. The method as claimed in claim 1 , wherein the CBD is in the form of a plant extract.
3. The method as claimed in claim 1 , wherein the CBD is in a pure or isolated form.